We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+9.9%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$30.8B
AUM Growth
+$2.83B
(+10%)
Cap. Flow
+$314M
Cap. Flow
% of AUM
1.02%
Top 10 Holdings %
Top 10 Hldgs %
29.43%
Holding
995
New
101
Increased
392
Reduced
278
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$434M |
| 2 |
Estee Lauder
EL
|
+$90.8M |
| 3 |
Visa
V
|
+$90M |
| 4 |
Amphenol
APH
|
+$67.6M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$57.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$409M |
| 2 |
CTXS
Citrix Systems Inc
CTXS
|
+$322M |
| 3 |
Apple
AAPL
|
+$115M |
| 4 |
TotalEnergies
TTE
|
+$31.5M |
| 5 |
Deckers Outdoor
DECK
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.08% |
| 2 | Healthcare | 15.56% |
| 3 | Financials | 11.89% |
| 4 | Industrials | 9.57% |
| 5 | Energy | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Aflac
AFL
$63.9B
| $826K | ﹤0.01% |
24,716
+774
| +3% | +$25.4K |
|
552
Halliburton
HAL
$27.9B
| $826K | ﹤0.01% |
16,284
-100
| -0.6% | -$5.17K |
|
553
Regeneron Pharmaceuticals
REGN
$68.8B
| $794K | ﹤0.01% |
2,883
+350
| +14% | +$101K |
|
554
Vanguard Growth ETF
VUG
$216B
| $785K | ﹤0.01% |
50,676
-40,350
| -44% | -$596K |
|
|
CPN
555
DELISTED
Calpine Corporation
CPN
| $775K | ﹤0.01% |
39,726
-4,821
| -11% | -$93.7K |
|
556
Factset
FDS
$9.05B
| $769K | ﹤0.01% |
7,080
+200
| +3% | +$22.2K |
|
557
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
| $765K | ﹤0.01% |
16,395
+2,558
| +18% | +$117K |
|
558
iShares North American Natural Resources ETF
IGE
$747M
| $761K | ﹤0.01% |
17,537
+992
| +6% | +$42.3K |
|
|
CBB.PRB
559
DELISTED
Cincinnati Bell Inc. DEP SHS
CBB.PRB
| $760K | ﹤0.01% |
16,800
| – | – |
|
560
Vanguard Russell 1000 Growth ETF
VONG
$42.5B
| $753K | ﹤0.01% |
34,160
-2,284
| -6% | -$48.1K |
|
|
YHOO
561
DELISTED
Yahoo Inc
YHOO
| $748K | ﹤0.01% |
18,490
+1,900
| +11% | +$68.2K |
|
562
Vanguard Russell 1000 Value ETF
VONV
$20.4B
| $745K | ﹤0.01% |
18,108
-366
| -2% | -$14.5K |
|
|
ATML
563
DELISTED
ATMEL CORP
ATML
| $737K | ﹤0.01% |
94,010
+21,120
| +29% | +$155K |
|
564
Southern Company
SO
$110B
| $733K | ﹤0.01% |
17,841
-3,079
| -15% | -$127K |
|
565
Wolfspeed
WOLF
$1.2B
| $732K | ﹤0.01% |
+11,715
| New | +$723K |
|
566
Iridium Communications
IRDM
$4.85B
| $728K | ﹤0.01% |
116,463
| – | – |
|
|
EEQ
567
DELISTED
Enbridge Energy Management Llc
EEQ
| $726K | ﹤0.01% |
39,114
+1,024
| +3% | +$18.7K |
|
568
Teva Pharmaceuticals
TEVA
$35.9B
| $725K | ﹤0.01% |
18,074
+2,350
| +15% | +$92.5K |
|
569
Scorpio Tankers
STNG
$3.96B
| $724K | ﹤0.01% |
6,135
+685
| +13% | +$76.8K |
|
570
Newell Brands
NWL
$2.16B
| $717K | ﹤0.01% |
22,152
+750
| +4% | +$22.3K |
|
571
Blackstone
BX
$104B
| $716K | ﹤0.01% |
23,147
+203
| +0.9% | +$5.53K |
|
|
SASR
572
DELISTED
Sandy Spring Bancorp Inc
SASR
| $714K | ﹤0.01% |
25,336
-500
| -2% | -$13.1K |
|
|
DFS
573
DELISTED
Discover Financial Services
DFS
| $713K | ﹤0.01% |
12,753
+8,102
| +174% | +$425K |
|
|
PMFG
574
DELISTED
PMFG INC COM STK (DE)
PMFG
| $708K | ﹤0.01% |
78,201
-12,138
| -13% | -$94.7K |
|
575
Northrop Grumman
NOC
$77B
| $707K | ﹤0.01% |
6,161
-28
| -0.5% | -$3K |
|
Similar funds
QCM
Brown Advisory's Q4 2013 Portfolio in Review
As of Q4 2013, Brown Advisory held 995 positions worth $30.8B, up 10% from $28B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Brown Advisory's Q4 2013 filing shows 101 new, 392 increased, 278 reduced and 51 closed positions. Its largest new stake was Plains GP Holdings: 157,910 shares worth $11.3M. The largest sale was Idexx Laboratories, an estimated $409M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q4 2013 buy was Plains GP Holdings: 157,910 shares worth $11.3M.
- Brown Advisory added most to Gilead Sciences in Q4 2013, an estimated $434M increase.
- Brown Advisory's biggest Q4 2013 reduction was Idexx Laboratories, cutting an estimated $409M.
- Brown Advisory fully exited Ariad Pharmaceuticals Inc in Q4 2013, selling an estimated $19.5M.
- Brown Advisory's ten largest holdings make up 29% of its $30.8B portfolio in Q4 2013.
- Brown Advisory opened 101 new positions and closed 51 in Q4 2013.
- Brown Advisory's portfolio value rose 10% quarter-over-quarter to $30.8B.
Based on Brown Advisory's 13F filing for Q4 2013, filed 11 Feb 2014.